Showing results (221-230 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|June 23, 2025
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical TrialsYu-Yun Shao, Andrei R Akhmetzhanov
Liver Cancer|June 23, 2025
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular CarcinomaEisuke Ueshima, Keitaro Sofue, Takahiro Kodama, et al.
Liver Cancer|June 30, 2025
Transarterial Chemoembolization plus Sorafenib versus Sorafenib Alone in Advanced Hepatocellular Carcinoma (SELECT): A Multicenter, Phase 3, Randomized, Controlled TrialYan Zhao, Wei Bai, Rong Ding, et al.
Liver Cancer|June 23, 2025
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)Yu Yang, Juxian Sun, Jianqiang Cai, et al.
Liver Cancer|July 11, 2025
Updated Network Meta-Analysis of First-Line Systemic Treatments for Advanced HCC: Consistent Role of TACEYe Rim Kim, Euichang Kim, Ha Il Kim, et al.
Liver Cancer|July 18, 2025
Fever following Treatment with Atezolizumab plus Bevacizumab Predicts Liver Injury in Patients with Unresectable Hepatocellular Carcinoma: A Prospective Observational AnalysisTakanori Ito, Takafumi Yamamoto, Kazuki Nishida, et al.
Liver Cancer|May 8, 2025
Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver DiseaseJessica Spiers, Wenhao Li, Aloysious D Aravinthan, et al.
Liver Cancer|October 9, 2025
Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular CarcinomaKazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, et al.
Liver Cancer|October 9, 2025
Immune and Histopathological Biomarkers for Prognosis and Neoadjuvant Immunotherapy Response in Intrahepatic CholangiocarcinomaN Jannah M Nasir, Edwin J C Chew, Kai Zhu, et al.
Liver Cancer|October 9, 2025
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse StudyAlessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, et al.
Pageof 55